BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, Wenzel J, Braegelmann C. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel) 2021;9:944. [PMID: 34579181 DOI: 10.3390/vaccines9090944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu P, Li C, Chang Y, Chen C, Wu C, Ma S. Management of Atopic Dermatitis During the COVID-19 Pandemic: Key Questions and Review of the Current Evidence. Dermatitis® 2023. [DOI: 10.1089/derm.2022.29019.pwu] [Reference Citation Analysis]
2 Begum F, Panda M, Das A. COVID vaccines inciting lepra reaction: An observation in a referral centre. CSDM 2023;3:11. [DOI: 10.25259/csdm_140_2022] [Reference Citation Analysis]
3 Agustin M, Trifitriana M, Danarti R. COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review. BMC Infect Dis 2023;23:7. [PMID: 36609222 DOI: 10.1186/s12879-022-07973-4] [Reference Citation Analysis]
4 Patil D, Suparna M, Shivaswamy K, Sumathy T. Dermatomyositis: severe acute respiratory syndrome coronavirus 2, an initiator or a trigger? J Egypt Womens Dermatol Soc 2023;20:52. [DOI: 10.4103/jewd.jewd_36_22] [Reference Citation Analysis]
5 Poli MA, Ambrogio F, De Marco A, Messina R, AntonioVena G, Cassano N, Cazzato G, Filotico R, Bonamonte D, Romita P, Foti C. A 39-year-old woman with non-follicular pustules on targetoid plaques during treatment for in vitro fertilization and embryo transfer. Intern Emerg Med 2022;:1-4. [PMID: 36575279 DOI: 10.1007/s11739-022-03178-4] [Reference Citation Analysis]
6 Bresler SC, Menge TD, Tejasvi T, Carty SA, Hristov AC. Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID-19 vaccination: A reactive lymphomatoid papulosis-like eruption and a bona fide lymphoma. J Cutan Pathol 2022. [PMID: 36437812 DOI: 10.1111/cup.14371] [Reference Citation Analysis]
7 Gamonal SBL, Marques NCV, Pereira HMB, Gamonal ACC. Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin. Dermatol Ther 2022;35:e15899. [PMID: 36196603 DOI: 10.1111/dth.15899] [Reference Citation Analysis]
8 Kultawanich K, Sampattavanich N. Local bullous reaction as a cutaneous reaction after m RNA ‐boosted vaccination in a post‐ COVID patient. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6610] [Reference Citation Analysis]
9 Wu PC, Huang IH, Wang CW, Tsai CC, Chung WH, Chen CB. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review. Am J Clin Dermatol 2022. [PMID: 36048409 DOI: 10.1007/s40257-022-00721-z] [Reference Citation Analysis]
10 Al‐muqarrab FJ, Alakloby OM, Al Ameer MA, Alhajri AM. Cutaneous reactions post‐COVID‐19 vaccination. Case series and literature review. JEADV Clinical Practice 2022. [DOI: 10.1002/jvc2.56] [Reference Citation Analysis]
11 Seo MG, Choi EK, Chung KJ. Delayed inflammatory response evoked in nasal alloplastic implants after COVID-19 vaccination: A case report. World J Clin Cases 2022; 10(23): 8298-8303 [DOI: 10.12998/wjcc.v10.i23.8298] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Quintero D, Patel N, Harris G, Maristany A, Alani A, Rosenberg AE, Conway SA, Jose J. COVID-19 vaccine-associated ganulomatous mass mimicking a sarcoma: a case report. Radiology Case Reports 2022;17:2775-8. [DOI: 10.1016/j.radcr.2022.05.035] [Reference Citation Analysis]
13 Sydow E, Mustafa AS, Hanif A, Tunio J, Hanif SNM. Recent Updates on mRNA Vaccines. Vaccines (Basel) 2022;10:1209. [PMID: 36016096 DOI: 10.3390/vaccines10081209] [Reference Citation Analysis]
14 Hsieh M, Yamaguchi Y. Immune Response in Regard to Hypersensitivity Reactions after COVID-19 Vaccination. Biomedicines 2022;10:1641. [DOI: 10.3390/biomedicines10071641] [Reference Citation Analysis]
15 Dadras O, Mehraeen E, Karimi A, Tantuoyir MM, Afzalian A, Nazarian N, Mojdeganlou H, Mirzapour P, Shamsabadi A, Dashti M, Ghasemzadeh A, Vahedi F, Shobeiri P, Pashaei Z, SeyedAlinaghi S. Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review. Arch Acad Emerg Med 2022;10:e54. [PMID: 36033990 DOI: 10.22037/aaem.v10i1.1585] [Reference Citation Analysis]
16 Copaescu AM, Rosa Duque JS, Phillips EJ. What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later. Ann Allergy Asthma Immunol 2022;129:40-51. [PMID: 35390476 DOI: 10.1016/j.anai.2022.03.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Siripipattanamongkol N, Rattanasak S, Taiyaitieng C, Inthajak Y, Kuawatcharawong N, Sukasem C, Tempark T. Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing. Pediatr Dermatol 2022;39:601-5. [PMID: 36000937 DOI: 10.1111/pde.15074] [Reference Citation Analysis]
18 Parsaei A, Rezaei SS, Rahmani A, Masoumi M, Dehghanbanadaki H, Norouzi S, Riyahi MM, Tabaraii R, Montazeri SMH. Scleromyxedema in an adult following Sinopharm BBIBP-CorV vaccination: An extremely rare phenomenon. Journal of Scleroderma and Related Disorders. [DOI: 10.1177/23971983221107321] [Reference Citation Analysis]
19 Toyama Y, Kamiya K, Maekawa T, Komine M, Ohtsuki M. Pyoderma gangrenosum following vaccination against coronavirus disease-2019: a case report. Int J Dermatol 2022. [PMID: 35567368 DOI: 10.1111/ijd.16255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Pour Mohammad A, Mashayekhi F, Seirafianpour F, Gholizadeh Mesgarha M, Goodarzi A. COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Doyle C, Watchorn RE. Persistent pruritus following COVID-19 vaccination. Ir J Med Sci 2022. [PMID: 35199304 DOI: 10.1007/s11845-022-02959-2] [Reference Citation Analysis]
22 Alamri A, Alghamdi Y, Alamri SJ, Althaqafi MK, Alqurashi W, Bader BA, Mohanna AT, Almahdi B. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. Cureus 2022. [DOI: 10.7759/cureus.22414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Bhargava A, Kharkar V, Mahajan S, Gole P. Neutrophilic pustular eruption with behcet's like illness post Covid-19 vaccination. Indian Dermatol Online J 2022;13:493. [DOI: 10.4103/idoj.idoj_29_22] [Reference Citation Analysis]
24 Oskay T, Isık M. Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination. Clin Rheumatol 2021. [PMID: 34853922 DOI: 10.1007/s10067-021-05993-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
25 Iwasawa O, Kamiya K, Okada H, Komine M, Ohtsuki M. A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination. J Dermatol 2021. [PMID: 34821411 DOI: 10.1111/1346-8138.16257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Atak MF, Farabi B, Kalelioglu MB, Rao BK. Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration. J Cosmet Dermatol 2021. [PMID: 34791786 DOI: 10.1111/jocd.14607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology (Basel) 2021;8:463-76. [PMID: 34698094 DOI: 10.3390/dermatopathology8040049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]